KINETA, INC.

• SEATTLE, WA How do I update this listing?

Create Email Alert

Kineta is based out of Seattle. Proteostasis Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on the discovery and development of novel therapeutics that treat diseases caused by an imbalance in the proteostasis network. Proteostasis Therapeutics operates in the United States.Whalewisdom has at least 70 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2022-12-29. The notice included securities offered of Equity

Contact Info

kineta, inc.
219 TERRY AVE. N.
SEATTLE WA    98109
Business Phone: (206) 378-0400
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2022-12-29 D BIOTECHNOLOGY Equity 30,000,000 7,500,000 22,500,000
2021-01-06 D OTHER HEALTH CARE Equity 33,599,895 33,599,895 0
2015-09-15 D/A BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 15,000,000 15,000,000 0
2015-09-15 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 27,999,992 21,999,992 6,000,000
2014-10-07 D/A BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 10,000,000 5,000,000 5,000,000
2014-08-14 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 10,000,000 3,012,271 6,987,729
2011-06-02 D/A OTHER HEALTH CARE Equity 81,760,000 70,623,000 11,137,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHRISTOPHER K. MIRABELLI subscription required
    DIRECTOR
STEPHEN KNIGHT, M.D. subscription required
    DIRECTOR
ALAN WALTS, PH.D. subscription required
    DIRECTOR
LAUREN SILVERMAN, PH.D. subscription required
    DIRECTOR
JEFFERY W. KELLY subscription required
    DIRECTOR
CHRISTOPHER T. WALSH subscription required
    DIRECTOR
PETER H. REINHART subscription required
    EXECUTIVE OFFICER DIRECTOR PROMOTER
PAULINE JEN RYAN subscription required
    EXECUTIVE OFFICER
MEENU CHHABRA subscription required
    EXECUTIVE OFFICER
MARKUS HAEBERLEIN subscription required
    EXECUTIVE OFFICER
JEFFREY GOLDBERG subscription required
    EXECUTIVE OFFICER
WALTER NEWMAN subscription required
    EXECUTIVE OFFICER
JANET SMART subscription required
    EXECUTIVE OFFICER
MICHAEL CASEY subscription required
    EXECUTIVE OFFICER
BERNARD DAVITIAN subscription required
    DIRECTOR
LAUREN SILVERMAN subscription required
    DIRECTOR
STEPHEN KNIGHT subscription required
    DIRECTOR
M. JAMES BARRETT subscription required
    DIRECTOR
HENRY SKINNER subscription required
    DIRECTOR
CONOR WALSHE subscription required
    DIRECTOR
NADIA USTARIZ subscription required
    EXECUTIVE OFFICER
IRENA MELNIKOVA subscription required
    PROMOTER
RICHARD PETERS subscription required
    EXECUTIVE OFFICER DIRECTOR
N. ANTHONY COLES subscription required
    EXECUTIVE OFFICER DIRECTOR
PAULASH MOHSEN subscription required
    EXECUTIVE OFFICER
BRIGITTE ROBERTSON subscription required
    EXECUTIVE OFFICER
PATRICIA L. ALLEN subscription required
    DIRECTOR
DAVID ARKOWITZ subscription required
    DIRECTOR
KIM C. DRAPKIN subscription required
    DIRECTOR
RICHARD A. HEYMAN subscription required
    DIRECTOR
CECIL B. PICKETT subscription required
    DIRECTOR
LYNNE ZYDOWSKY subscription required
    DIRECTOR
SHAWN IADONATO subscription required
    EXECUTIVE OFFICER DIRECTOR
MARION R. FOOTE subscription required
    DIRECTOR
RAYMOND BARTOSZEK subscription required
    DIRECTOR
CRAIG W. PHILIPS subscription required
    EXECUTIVE OFFICER
KEITH A. BAKER subscription required
    EXECUTIVE OFFICER

Elevate your investments